European Medicines Agency to Review Yaz Risks

Law360 reports that the European Medicines Agency (EMA) announced on Monday that it will meet in February 2013 to review the adverse side effects associated with third- and fourth-generation hormonal birth control pills such as Yaz. The EMA’s Pharmacovigilance Risk Assessment Committee will investigate whether to restrict later generation hormonal birth control pills, such as Yaz, to patients who are not able to take other contraceptives. [Read more…]

Attorney Paulina do Amaral Provides a Video Update on Yaz Birth Control Injury Lawsuits

Over $750 million to date has been paid out to women who developed blood clots and other serious side effects from Yaz, Yasmin, Gianvi, and Ocella birth control pills. All of these medications are manufactured by Bayer. To date, Bayer has settled 3,500 of these birth control drug injury lawsuits. [Read more…]